Analyst firms · Evercore ISI · EFX
Evercore ISI EFX price target and rating history
Equifax Inc. (EFX) · Finance
Evercore ISI rates Equifax Inc. (EFX) Outperform with a $310 price target, as of its latest action on Feb 13, 2024. It has published 3 rating actions on EFX since October 2021, including 1 upgrade and 1 downgrade. Across 6 firms with a EFX price target in the last 12 months, the median target is $228.50.
- Current rating
- Outperform
- Price target
- $310
- Median target, all firms
- $228.50
- Actions on EFX
- 3
Evercore ISI price target on EFX
Every Evercore ISI rating on EFX
- Feb 13, 2024
- Apr 21, 2022
- Oct 15, 2021
How other firms rate EFX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Sector Perform | $189 | Oct 26, 2026 |
| Argus Research | Buy | $200 | Oct 22, 2026 |
| Oppenheimer | Perform | Oct 16, 2026 | |
| BNP Paribas Exane | Outperform | $245 | Sep 8, 2026 |
| Rothschild & Co Redburn | Buy | $235 | Aug 21, 2026 |
| Mizuho | Outperform | $222 | Apr 16, 2026 |
| BofA Securities | Buy | $250 | Feb 17, 2026 |
Questions about Evercore ISI and EFX
- What is Evercore ISI's price target for EFX?
- Evercore ISI's latest stated price target for Equifax Inc. (EFX) is $310, from its action on Feb 13, 2024.
- What is Evercore ISI's rating on EFX?
- Evercore ISI rates EFX Outperform, a bullish rating, as of Feb 13, 2024.
- When did Evercore ISI last change its view on EFX?
- On Feb 13, 2024, Evercore ISI upgrades to Outperform from In-line, price target $210 to $310.
- How does Evercore ISI's EFX target compare with other analysts?
- Across 6 firms with a EFX price target in the last 12 months, the median target is $228.50.
More EFX rating histories
- RBC Capital Markets7
- Argus Research3
- Oppenheimer3
- BNP Paribas Exane6
- BofA Securities6
- Morgan Stanley8
- Wells Fargo3
- Needham4
All Evercore ISI ratingsEFX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.